Literature DB >> 24251323

Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.

Paul Moayyedi, Yuhong Yuan, Grigorios Leontiadis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24251323      PMCID： PMC3805341          DOI： 10.1155/2013/321379

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  29 in total

1.  Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.

Authors:  Shelly L Gray; Andrea Z LaCroix; Joseph Larson; John Robbins; Jane A Cauley; JoAnn E Manson; Zhao Chen
Journal:  Arch Intern Med       Date:  2010-05-10

2.  Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study.

Authors:  Hui-Fen Chiu; Ya-Wen Huang; Chih-Ching Chang; Chun-Yuh Yang
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11       Impact factor: 2.890

3.  Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.

Authors:  Laura E Targownik; Lisa M Lix; Stella Leung; William D Leslie
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

4.  Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao; Charles Quesenberry
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

5.  Acid-suppressive medications and risk of bone loss and fracture in older adults.

Authors:  Elaine W Yu; Terri Blackwell; Kristine E Ensrud; Teresa A Hillier; Nancy E Lane; Eric Orwoll; Douglas C Bauer
Journal:  Calcif Tissue Int       Date:  2008-09-24       Impact factor: 4.333

Review 6.  Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.

Authors:  Paul Moayyedi; Ann Cranney
Journal:  Am J Gastroenterol       Date:  2008-10       Impact factor: 10.864

7.  Effectiveness of bisphosphonate therapy in a community setting.

Authors:  Adrianne C Feldstein; Derek Weycker; Gregory A Nichols; Gerry Oster; Gabriela Rosales; David L Boardman; Nancy Perrin
Journal:  Bone       Date:  2008-09-26       Impact factor: 4.398

8.  Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates.

Authors:  F de Vries; A L Cooper; S M Cockle; T-P van Staa; C Cooper
Journal:  Osteoporos Int       Date:  2009-03-31       Impact factor: 4.507

9.  Increase in vertebral fracture risk in postmenopausal women using omeprazole.

Authors:  Christian Roux; Karine Briot; Laure Gossec; Sami Kolta; Tilo Blenk; Dieter Felsenberg; David M Reid; Richard Eastell; Claus C Glüer
Journal:  Calcif Tissue Int       Date:  2008-11-21       Impact factor: 4.333

10.  Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.

Authors:  S Pouwels; A Lalmohamed; P Souverein; C Cooper; B J Veldt; H G Leufkens; A de Boer; T van Staa; F de Vries
Journal:  Osteoporos Int       Date:  2010-06-29       Impact factor: 4.507
View more
  4 in total

Review 1.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

Review 2.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

3.  Proton pump inhibitors and risk of bone fractures.

Authors:  Grigorios I Leontiadis; Paul Moayyedi
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

4.  Cost Effectiveness of Gastroprotection with Proton Pump Inhibitors in Older Low-Dose Acetylsalicylic Acid Users in the Netherlands.

Authors:  Sek Hung Chau; Reinier L Sluiter; Wietske Kievit; Michel Wensing; Martina Teichert; Jacqueline G Hugtenburg
Journal:  Drugs Aging       Date:  2017-05       Impact factor: 3.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.